Johnson & Johnson (JNJ) Tops Q2 EPS by 19c, Offers FY Guidance

July 2020

April 2020

(0.8%) – 1.0%

(3.0%) - 0.5%

Operational Sales2

Change vs. Prior Year

$81.0 to $82.5

(1.3%) – 0.5%

$79.2 to $82.2

(3.5%) - 0.0%

Estimated Reported Sales3

Change vs. Prior Year

$79.9 to $81.4

(2.6%) – (0.8%)

$77.5 to $80.5

(5.5%) - (2.0%)

Adjusted Operational EPS (Diluted)2,4

Change vs. Prior Year

$7.85 to $8.05

(9.6%) - (7.3%)

$7.65 to $8.05

(11.9%) - (7.3%)

Adjusted EPS (Diluted)3,4

Change vs. Prior Year

$7.75 - $7.95

(10.7%) – (8.4%)

$7.50 to $7.90

(13.6%) - (9.0%)

1 Non-GAAP financial measure; excludes the net impact of acquisitions and divestitures

2 Non-GAAP financial measure; excludes the impact of translational currency

3 Calculated using Euro Average Rate: July 2020 = $1.12 Euro Average Rate: April 2020 = $1.09 (Illustrative purposes only)

4 Non-GAAP financial measure; excludes intangible amortization expense and special items